Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation-Reference-Cited by-同舟云学术

Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation

Published:2023-05 Issue:5 Volume:29 Page:332.e1-332.e11
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Shibata Sho,Arai Yasuyuki^ORCID,Kondo Tadakazu^ORCID,Mizuno Shohei,Harada Kaito,Miyakoshi Shigesaburo,Uchida Naoyuki,Maruyama Yumiko^ORCID,Eto Tetsuya,Katsuoka Yuna,Matsue Kosei,Nishiwaki Kaichi,Takada Satoru,Doki Noriko^ORCID,Itoh Mitsuru,Nagafuji Koji,Kawakita Toshiro,Tanaka Junji,Fukuda Takahiro,Atsuta Yoshiko^ORCID,Yanada Masamitsu^ORCID

Funder

Kyowa Hakko Kirin

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference37 articles.

1. Busulfan in hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2009

2. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS;de Lima;Blood,2004

3. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2;Chae;Bone Marrow Transplant,2007

4. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS;Andersson;Biol Blood Marrow Transplant,2008

5. Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide;Lee;Korean J Hematol,2010